Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 7/20 | 0.68 |
| ▸ | TOP2B | Q02880 | 7/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | CLK2 | P49760 | 1/20 | 0.51 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL584841 | 1.00 | TOP2A (0.68) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL500719 | 0.90 | TOP2A (0.71) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL29463823 | 0.90 | TOP2A (0.71) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL14209463 | 0.89 | TOP2A (0.55) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL10511131 | 0.88 | TOP2A (0.69) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| Potassium SCHEMBL10510827 | 0.88 | TOP2A (0.69) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL10511115 | 0.88 | TOP2A (0.69) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL10510815 | 0.88 | TOP2A (0.69) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL500386 | 0.86 | ALDH1A1 (0.66) | TOP2ATOP2BALDH1A1POLBOPRM1 | |
| SCHEMBL8324772 | 0.86 | TOP2A (0.64) | TOP2ATOP2BALDH1A1POLBOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115785095-B | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2023218472-A1 | AN AQUEOUS OPHTHALMIC SOLUTION OF NSAIDS AND FLUOROQUINOLONE ANTIBIOTIC AND PROCESS OF PREPARATION THEREOF | AKUMS DRUGS & PHARMACEUTICALS LIMITED (IN) | 2023-11-16 | — | — | WO | claimed |
| CN-218871961-U | Preparation facilities of moxifloxacin impurity | 江苏信和生物医药有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115785095-A | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-119936246-A | Method for detecting N-nitrosomoxifloxacin in moxifloxacin hydrochloride sodium chloride injection | 安徽博诺美科生物医药有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-118937545-B | Separation detection method for moxifloxacin and impurities thereof | 成都普什制药有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118937545-A | Separation detection method for moxifloxacin and impurities thereof | 成都普什制药有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-115785095-B | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-115785095-B | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-115785095-B | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118047721-A | Quinoline carboxylic acid derivative and application thereof | 沈阳中化农药化工研发有限公司 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023218472-A1 | AN AQUEOUS OPHTHALMIC SOLUTION OF NSAIDS AND FLUOROQUINOLONE ANTIBIOTIC AND PROCESS OF PREPARATION THEREOF | AKUMS DRUGS & PHARMACEUTICALS LIMITED (IN) | 2023-11-16 | — | — | WO | disclosed |
| CN-113092644-B | Method for simultaneously detecting content of moxifloxacin and intermediate thereof | 江苏八巨药业有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-218871961-U | Preparation facilities of moxifloxacin impurity | 江苏信和生物医药有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-218871961-U | Preparation facilities of moxifloxacin impurity | 江苏信和生物医药有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-218871961-U | Preparation facilities of moxifloxacin impurity | 江苏信和生物医药有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115785095-A | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115785095-A | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115785095-A | Preparation and purification method of moxifloxacin impurity RC-4 | 上海熙华药业有限公司 | 2023-03-14 | — | — | CN | disclosed |